ID   HKESC-1/cis
AC   CVCL_S525
DR   Wikidata; Q54889767
RX   PubMed=21177414;
CC   Population: Chinese.
CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D568 ! HKESC-1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
RX   PubMed=21177414; DOI=10.1124/mol.110.069393;
RA   Yu L., Chen M.-H., Li Z.-J., Wen J., Fu J.-H., Guo D., Jiang Y.,
RA   Wu S.-G., Cho C.-H., Liu S.-W.;
RT   "Celecoxib antagonizes the cytotoxicity of cisplatin in human
RT   esophageal squamous cell carcinoma cells by reducing intracellular
RT   cisplatin accumulation.";
RL   Mol. Pharmacol. 79:608-617(2011).
//